CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS EQUITY - USD ($) $ in Thousands	Total	Cumulative-Effect Adjustment (ASU 2016-13)	Preferred Stock	Common Stock	Additional Paid-In Capital	Retained Earnings	Retained Earnings Cumulative-Effect Adjustment (ASU 2016-13)	Treasury Stock	Accumulated Other Comprehensive Income (Loss)	Series B Preferred Stock Preferred Stock
Beginning balance at Dec. 31, 2020	$ 805,464		$ 10,438	$ 384	$ 587,165	$ 191,098		$ (1,668)	$ 18,047
Beginning balance, shares at Dec. 31, 2020			10,438	38,618,054
Net Income (Loss)	92,785					92,785
Other comprehensive income (loss), net of tax	(26,349)								(26,349)
Issuance of common stock upon exercise of stock options, net	1,456			$ 1	1,355			100
Issuance of common stock upon exercise of stock options net, shares				115,897
Restricted stock activity	(1,135)			$ 1	(1)			(1,135)
Restricted stock activity, shares				258,458
Issuance of common stock in connection with employee stock purchase plan	1,217			$ 1	1,216
Issuance of common stock in connection with employee stock purchase plan, shares				53,202
Cash dividends declared on preferred stock	(783)					(783)
Cash dividends declared on common stock	(11,424)					(11,424)
Repurchases of common stock	$ (28,867)							28,867
Repurchase of common stock, shares	1,331,708			(1,331,708)
Share-based compensation expense	$ 4,018				4,018
Ending balance at Dec. 31, 2021	836,382		$ 10,438	$ 387	593,753	271,676		(31,570)	(8,302)
Ending balance, shares at Dec. 31, 2021			10,438	37,713,903
Net Income (Loss)	87,954					87,954
Other comprehensive income (loss), net of tax	(109,248)								(109,248)
Issuance of common stock upon exercise of stock options, net	(2,588)				(592)			(1,996)
Issuance of common stock upon exercise of stock options net, shares				224,640
Restricted stock activity	(1,595)			$ 2	(197)			(1,400)
Restricted stock activity, shares				195,127
Issuance of common stock in connection with employee stock purchase plan	1,125			$ 0	(1)			1,126
Issuance of common stock in connection with employee stock purchase plan, shares				48,173
Redemption of Series B Preferred Stock	(10,438)									$ (10,438)
Stock Redeemed or Called During Period, Shares										(10,438)
Cash dividends declared on preferred stock	(196)					(196)
Cash dividends declared on common stock	(13,543)					(13,543)
Repurchases of common stock	$ (17,274)							(17,274)
Repurchase of common stock, shares	689,068			(689,068)
Share-based compensation expense	$ 5,334				5,334
Ending balance at Dec. 31, 2022	765,816	$ (10,097)	$ 0	$ 389	598,297	335,794	$ (10,097)	(51,114)	(117,550)
Ending balance, shares at Dec. 31, 2022			0	37,492,775
Net Income (Loss)	107,878					107,878
Other comprehensive income (loss), net of tax	17,433								17,433
Issuance of common stock upon exercise of stock options, net	$ 659			$ 1	658
Issuance of common stock upon exercise of stock options net, shares	59,153
Issuance of common stock and stock options due to business combination, net of issuance costs	$ 107,017			$ 59	106,958
Issuance of common stock and stock options due to business combination, net of issuance costs, shares				5,932,323
Restricted stock activity	(2,251)			$ 2	(2,140)			(113)
Restricted stock activity, shares				206,193
Issuance of common stock in connection with employee stock purchase plan	1,520				0			1,520
Issuance of common stock in connection with employee stock purchase plan, shares				73,612
Cash dividends declared on common stock	$ (14,636)					(14,636)
Repurchase of common stock, shares	0
Share-based compensation expense	$ 6,715				6,715
Ending balance at Dec. 31, 2023	$ 990,151		$ 0	$ 451	$ 710,488	$ 429,036		$ (49,707)	$ (100,117)
Ending balance, shares at Dec. 31, 2023			0	43,764,056